Skip to Main Content

Paper Details

Androgen receptor signalling impairs docetaxel efficacy in castration-resistant prostate cancer.
Br J Cancer
16
2020
Author NameAffiliation
Alice A GibsonThe Ohio State University
Alex SparreboomThe Ohio State University
Ronald de WitDepartment of Medical Oncology Erasmus MC-Cancer Institute
Martijn P LolkemaDepartment of Medical Oncology Erasmus MC-Cancer Institute
  • 1 - 4

Datasets

Release 1.2